OCUP - Ocuphire Pharma Chief Operating Officer Awarded $855K Worth of Stock Options | Benzinga
JOSEPH SCHACHLE, Chief Operating Officer at Ocuphire Pharma (NASDAQ:OCUP), reported a large acquisition of company stock options on November 27, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that SCHACHLE, Chief Operating Officer at Ocuphire Pharma, a company in the Health Care sector, was just awarded stock options worth 300,000 shares of OCUP. The options give SCHACHLE the right to buy the company's stock at $2.79 per share.
Ocuphire Pharma shares are trading up 2.15% at $2.85 at the time of this writing on Tuesday morning. Since the current price is $2.85, this makes SCHACHLE's 300,000 shares worth $855,000.